| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| DOUGLAS H WILT ACCOUNTING | 760 | 760 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 2,000 SHARES - SALIZ PHARMACEUTICALS, INC. | 2001-03 | Donated | 2012-03 | 105,790 | 17,954 | Cost | 87,836 | |||
| 1,000 SHARES - SALIZ PHARMACEUTICALS, INC. | 2012-10 | Donated | 2012-10 | 40,445 | Cost | 40,445 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 54,500 SHS SALIX PHARMACEUTICALS, INC. | 471,300 | 2,569,953 |
| 250 SHS ALCOA INC. | 9,535 | 6,170 |
| 260 SHS MANITOWOC CO., INC. | 9,636 | 4,077 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OFFICE EXPENSE |